IA
ALZN icon

IFG Advisory’s Alzamend Neuro ALZN Stock Holding History

IFG Advisory’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26 Buy
+22
New +$24 ﹤0.01% 2340

Other funds holding ALZN

KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

IFG Advisory's ALZN Position: Q2 2026 in Review

IFG Advisory opened a new position in Alzamend Neuro (ALZN) in Q2 2026: 22 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #2340 among its holdings.

11 funds tracked by Wall St. Rank hold ALZN as of Q2 2026.

  • IFG Advisory held 22 shares of Alzamend Neuro worth $26 as of Q2 2026.
  • Alzamend Neuro was a new IFG Advisory position in Q2 2026.
  • Alzamend Neuro made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #2340 holding.
  • 11 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.